{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:28:59Z","timestamp":1792506539688,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.vaccine.2007.11.092","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T08:05:14Z","timestamp":1200038714000},"page":"797-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV"],"prefix":"10.1016","volume":"26","author":[{"given":"Kumari G.","family":"Lokugamage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Yoshikawa-Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Wyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Te","family":"Kent Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 Suppl","key":"10.1016\/j.vaccine.2007.11.092_bib1","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.092_bib2","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1128\/JVI.02605-06","article-title":"Evolutionary insights into the ecology of coronaviruses","volume":"81","author":"Vijaykrishna","year":"2007","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.092_bib3","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.0409608102","article-title":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human","volume":"102","author":"Song","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2007.11.092_bib4","series-title":"Fields Virology","first-page":"605","article-title":"Emerging viral diseases","author":"Peters","year":"2007"},{"key":"10.1016\/j.vaccine.2007.11.092_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","author":"Masters","year":"2006","journal-title":"Adv Virus Res"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.092_bib6","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.virol.2004.04.005","article-title":"Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59","volume":"324","author":"Thackray","year":"2004","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.092_bib8","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JVI.77.8.4972-4978.2003","article-title":"Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism","volume":"77","author":"Navas","year":"2003","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2007.11.092_bib9","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.1128\/JVI.77.16.9084-9089.2003","article-title":"Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism","volume":"77","author":"Casais","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/viro.2000.0757","article-title":"Coronavirus spike proteins in viral entry and pathogenesis","volume":"279","author":"Gallagher","year":"2001","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.092_bib11","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1128\/JVI.73.9.7607-7618.1999","article-title":"Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence","volume":"73","author":"Sanchez","year":"1999","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.092_bib12","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1128\/JVI.73.9.7752-7760.1999","article-title":"Pathogenesis of chimeric MHV4\/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence","volume":"73","author":"Phillips","year":"1999","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2007.11.092_bib13","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1056\/NEJMp030078","article-title":"SARS-associated coronavirus","volume":"348","author":"Holmes","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.092_bib14","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1128\/JVI.79.6.3401-3408.2005","article-title":"B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein","volume":"79","author":"Zhong","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.092_bib15","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JVI.79.3.1906-1910.2005","article-title":"Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.092_bib16","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1128\/JVI.79.6.3289-3296.2005","article-title":"Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents","volume":"79","author":"Keng","year":"2005","journal-title":"J Virol"},{"issue":"6982","key":"10.1016\/j.vaccine.2007.11.092_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.vaccine.2007.11.092_bib18","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"10.1016\/j.vaccine.2007.11.092_bib19","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.0403492101","article-title":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity","volume":"101","author":"Buchholz","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.vaccine.2007.11.092_bib20","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/JVI.79.10.5900-5906.2005","article-title":"Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants","volume":"79","author":"Sui","year":"2005","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.11.092_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/427242","article-title":"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice","volume":"191","author":"Greenough","year":"2005","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.092_bib22","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.vaccine.2007.11.092_bib23","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.092_bib24","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/j.1460-2075.1996.tb00553.x","article-title":"Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes","volume":"15","author":"Vennema","year":"1996","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.virol.2005.02.001","article-title":"Spike protein assembly into the coronavirion: exploring the limits of its sequence requirements","volume":"334","author":"Bosch","year":"2005","journal-title":"Virology"},{"issue":"18","key":"10.1016\/j.vaccine.2007.11.092_bib26","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1128\/JVI.78.18.9904-9917.2004","article-title":"Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain","volume":"78","author":"Ye","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.092_bib27","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1128\/JVI.73.9.7441-7452.1999","article-title":"Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein","volume":"73","author":"de Haan","year":"1999","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.11.092_bib28","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/jvi.71.12.9278-9284.1997","article-title":"Protein interactions during coronavirus assembly","volume":"71","author":"Nguyen","year":"1997","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2007.11.092_bib29","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1128\/JVI.75.19.9059-9067.2001","article-title":"Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging","volume":"75","author":"Narayanan","year":"2001","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.11.092_bib30","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1128\/JVI.76.10.4987-4999.2002","article-title":"Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus","volume":"76","author":"Kuo","year":"2002","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2007.11.092_bib31","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1128\/JVI.74.17.8127-8134.2000","article-title":"Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells","volume":"74","author":"Narayanan","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.092_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/jvi.33.1.449-462.1980","article-title":"Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid","volume":"33","author":"Sturman","year":"1980","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.092_bib33","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1128\/JVI.77.5.2922-2927.2003","article-title":"Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal","volume":"77","author":"Narayanan","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/viro.1999.9955","article-title":"Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells","volume":"263","author":"Maeda","year":"1999","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.092_bib35","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1128\/JVI.72.11.8636-8643.1998","article-title":"Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes","volume":"72","author":"Baudoux","year":"1998","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2007.11.092_bib36","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.1128\/JVI.00414-06","article-title":"Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein","volume":"80","author":"Huang","year":"2006","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.11.092_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.febslet.2004.09.009","article-title":"Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system","volume":"576","author":"Mortola","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2007.11.092_bib38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2567.2007.02676.x","article-title":"Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice","volume":"122","author":"Lu","year":"2007","journal-title":"Immunology"},{"issue":"22","key":"10.1016\/j.vaccine.2007.11.092_bib39","doi-asserted-by":"crossref","first-page":"12557","DOI":"10.1128\/JVI.78.22.12557-12565.2004","article-title":"Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production","volume":"78","author":"Huang","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.092_bib40","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/JVI.74.3.1393-1406.2000","article-title":"Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier","volume":"74","author":"Kuo","year":"2000","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.092_bib41","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/JVI.01702-06","article-title":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor","volume":"81","author":"Tseng","year":"2007","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1083\/jcb.131.2.339","article-title":"Envelope glycoprotein interactions in coronavirus assembly","volume":"131","author":"Opstelten","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1016\/j.vaccine.2007.11.092_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2172-7-25","article-title":"Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters","volume":"7","author":"Azizi","year":"2006","journal-title":"BMC Immunol"},{"issue":"28","key":"10.1016\/j.vaccine.2007.11.092_bib44","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.vaccine.2005.02.014","article-title":"A pre-S\/S CHO-derived hepatitis B virus vaccine protects woodchucks from WHV productive infection","volume":"23","author":"Argentini","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.092_bib45","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/IAI.71.8.4536-4543.2003","article-title":"DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses","volume":"71","author":"Baruch","year":"2003","journal-title":"Infect Immun"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2007.11.092_bib46","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.092_bib47","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1128\/jvi.64.6.2788-2795.1990","article-title":"Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus","volume":"64","author":"Yasuda","year":"1990","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine","volume":"340","author":"Kapadia","year":"2005","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.092_bib49","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JVI.79.5.2678-2688.2005","article-title":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region","volume":"79","author":"Chen","year":"2005","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.092_bib50","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.vaccine.2005.08.055","article-title":"A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses","volume":"24","author":"Spruth","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.11.092_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/104454904323145272","article-title":"Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB\/c mice","volume":"23","author":"Tang","year":"2004","journal-title":"DNA Cell Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.imlet.2004.06.014","article-title":"Immunogenicity of SARS inactivated vaccine in BALB\/c mice","volume":"95","author":"Xiong","year":"2004","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib53","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbrc.2004.10.052","article-title":"Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry","volume":"325","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"42","key":"10.1016\/j.vaccine.2007.11.092_bib54","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1016\/j.vaccine.2005.05.023","article-title":"SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus","volume":"23","author":"Woo","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2007.11.092_bib55","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1128\/JVI.00083-06","article-title":"Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design","volume":"80","author":"He","year":"2006","journal-title":"J Virol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2007.11.092_bib56","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.vaccine.2005.01.033","article-title":"Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets","volume":"23","author":"Czub","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.11.092_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2006.12.011","article-title":"Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies","author":"Kuate","year":"2007","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.092_bib58","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1128\/JVI.80.8.4079-4087.2006","article-title":"Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice","volume":"80","author":"Lee","year":"2006","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.11.092_bib59","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/JVI.77.8.4528-4538.2003","article-title":"Switching species tropism: an effective way to manipulate the feline coronavirus genome","volume":"77","author":"Haijema","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.092_bib60","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1128\/JVI.74.3.1566-1571.2000","article-title":"Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein","volume":"74","author":"Godeke","year":"2000","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.11.092_bib61","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.092_bib62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: passport to immune recognition","volume":"40","author":"Grgacic","year":"2006","journal-title":"Methods"},{"issue":"9427","key":"10.1016\/j.vaccine.2007.11.092_bib63","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"ter Meulen","year":"2004","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2007.11.092_bib64","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.vaccine.2006.10.031","article-title":"Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model","volume":"25","author":"Du","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.092_bib65","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2006.03.049","article-title":"Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: implication for developing SARS vaccines","volume":"353","author":"Du","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2005.01.042","article-title":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein","volume":"334","author":"Bisht","year":"2005","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2007.11.092_bib67","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/500143","article-title":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters","volume":"193","author":"Roberts","year":"2006","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2007.11.092_bib68","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.092_bib69","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/jvi.64.3.1407-1409.1990","article-title":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization","volume":"64","author":"Vennema","year":"1990","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.11.092_bib70","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nri1732","article-title":"Immunopathogenesis of coronavirus infections: implications for SARS","volume":"5","author":"Perlman","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0147-9571(81)90003-5","article-title":"Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever","volume":"4","author":"Weiss","year":"1981","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib72","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/jvi.66.2.956-965.1992","article-title":"Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages","volume":"66","author":"Olsen","year":"1992","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.11.092_bib73","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1128\/jvi.66.11.6695-6705.1992","article-title":"Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus","volume":"66","author":"Corapi","year":"1992","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.11.092_bib74","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1073\/pnas.0409065102","article-title":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses","volume":"102","author":"Yang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/j.vaccine.2007.11.092_bib75","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1128\/JVI.79.22.13915-13923.2005","article-title":"Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization","volume":"79","author":"Kong","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.11.092_bib76","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2007.11.092_bib77","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1128\/JVI.00505-07","article-title":"Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice","volume":"81","author":"Rockx","year":"2007","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.11.092_bib78","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters","volume":"79","author":"Roberts","year":"2005","journal-title":"J Virol"},{"issue":"6961","key":"10.1016\/j.vaccine.2007.11.092_bib79","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/425915a","article-title":"Virology: SARS virus infection of cats and ferrets","volume":"425","author":"Martina","year":"2003","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.vaccine.2007.11.092_bib80","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07014326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07014326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:15:45Z","timestamp":1759400145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07014326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0264410X07014326"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}